The Academic Research Consortium (ARC)-2 initiative revisited the clinical and
angiographic end point definitions in coronary device trials, proposed in 2007, to make them …

Objective To assess whether weight loss interventions for adults with obesity affect all cause,
cardiovascular, and cancer mortality, cardiovascular disease, cancer, and body weight …

The systemic amyloidoses are a broad spectrum of diseases that result from misfolding of
proteins that aggregate into b-sheet amyloid fibrils. Over 35 amyloidogenic precursor …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Background The benefit of percutaneous coronary intervention (PCI) in patients with stable
coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic …

Background Drug combinations rather than increasing doses of one drug can achieve
greater efficacy and lower risks. Thus, as an alternative to high-intensity statin monotherapy …

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk
Reduction in Patients With Type 2 Diabetes: A Report of the American College of …

Background: Myocarditis is an uncommon, but potentially fatal, toxicity of immune checkpoint
inhibitors (ICI). Myocarditis after ICI has not been well characterized. Objectives: The authors …

Background Embolic strokes of undetermined source represent 20% of ischemic strokes and
are associated with a high rate of recurrence. Anticoagulant treatment with rivaroxaban, an …

Background Cardiovascular risk is increased in patients with gout. We compared
cardiovascular outcomes associated with febuxostat, a nonpurine xanthine oxidase inhibitor …